Sign Up Today and Learn More About Adagio Medical Stock
Invest in or calculate the value of your shares in Adagio Medical or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Adagio Medical Stock (ADME)
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
About Adagio Medical Stock
Founded
2011
Headquarters
Laguna Hills, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases. Adagio Medical is committed to providing electrophysiologists innovative cryoablation catheters that create safe, continuous, transmural lesions to treat cardiac arrhythmias anywhere in the heart, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded in 2011 and is based in Laguna Hills, California.
Adagio Medical Press Mentions
Stay in the know about the latest news on Adagio Medical
Adagio Medical Reports Second Quarter 2026 Results
biospace • Aug 11, 2026
Adagio Treats First Patient with Next-Gen Ablation System
ocbj • Aug 05, 2026
Why Palantir Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
benzinga • Aug 04, 2026
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours
benzinga • Aug 04, 2026
Adagio Medical Announces Positive Study Results for the vCLAS Ventricular Ablation System
mpo-mag • Jul 10, 2026
Adagio Medical Management
Leadership team at Adagio Medical
Founder, Chief Executive Officer and President
Olav Bergheim
CFO
Hugh A.Neuharth
Join now and verify your accreditation status to gain access to:
- Adagio Medical Current Valuation
- Adagio Medical Stock Price
- Adagio Medical Management
- Available deals in Adagio Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Adagio Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- Adagio Medical Revenue and Financials
- Adagio Medical Highlights
- Adagio Medical Business Model
- Adagio Medical Risk Factors
- Adagio Medical Research Report from SACRA Research
Trading Adagio Medical Stock
How to invest in Adagio Medical stock?
Accredited investors can buy pre-IPO stock in companies like Adagio Medical through EquityZen funds. These investments are made available by existing Adagio Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Adagio Medical stock?
Shareholders can sell their Adagio Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 56K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
